Considerations & Potential Risks While the benefits are promising, GLP-1RA users have also reported some increased risks, including: Gastrointestinal issues (nausea, heartburn, abdominal pain, and gastroparesis)
[DOI] [PMC free article] [PubMed] [Google Scholar] 19.Garvey W.T., Batterham R.L., Bhatta M., Buscemi S., Christensen L.N., Frias J.P., Jodar E., Kandler K., Rigas G., Wadden T.A., et al
Moreover, GLP-1 and GLP-1 receptor agonists increase satiety, leading to a reduction in weight (95)
[1] [2] These medications include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and others
These medications may be especially helpful for people with both diabetes and kidney problems
For example, if you're unsure whether you received the full dose, do not administer additional medication without medical advice